Literature DB >> 32533213

Stress urinary incontinence after transvaginal mesh surgery for anterior and apical prolapse: preoperative risk factors.

Mathilde Bideau1, Lucie Allègre2, Geertje Callewaert2,3, Brigitte Fatton2, Renaud de Tayrac2.   

Abstract

INTRODUCTION AND HYPOTHESIS: Debate persists over whether surgery to correct pelvic organ prolapse (POP) should be combined with midurethral sling (MUS) insertion. The aim of this study was to evaluate the incidence of stress urinary incontinence (SUI) up to 12 months after transvaginal mesh surgery, with or without MUS, and to identify risk factors for postoperative SUI.
METHODS: This retrospective single-center study included patients who underwent transvaginal mesh surgery with Uphold™ between October 2010 and December 2017. The primary outcome was the prevalence of SUI at 12 months postoperatively. Univariate and multivariate logistic regression was used to identify risks factors for postoperative SUI.
RESULTS: Of the 308 women included, 123 (40%) were continent (no SUI), 108 (35%) had SUI, and 76 (25%) had occult SUI. Forty-nine patients (15.9%) had a concomitant MUS procedure. At 12 months after surgery, 35.9% of patients without concomitant MUS had SUI vs 14.3% with (p = 0.003). Thirty-five patients (29%) developed de novo SUI. Postoperative complications were more common in patients with concomitant MUS (30.6% vs 17%; p = 0.003). The best predictor of postoperative SUI was the presence of preoperative SUI (OR 2.52 (1.25-5.09). Concomitant MUS (p < 0.001), and prior POP surgery (p = 0.034) were protective factors for postoperative SUI.
CONCLUSION: Preoperative SUI is the most important risk factor for postoperative SUI. However, given the higher risk of postoperative complications with concomitant MUS and the acceptable rate of de novo SUI rate without it, two-stage surgery seems preferable for patients with preoperative SUI.

Entities:  

Keywords:  Anterior sacrospinous ligament fixation; Pelvic organ prolapse; Polypropylene mesh; Stress urinary incontinence; Vaginal surgery

Year:  2020        PMID: 32533213     DOI: 10.1007/s00192-020-04363-9

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  5 in total

1.  Postoperative Outcomes Following Tension-Free Vaginal Mesh Surgery for Pelvic Organ Prolapse: A Retrospective Study.

Authors:  Aki Oride; Haruhiko Kanasaki; Tomomi Hara; Satoru Kyo
Journal:  Urol J       Date:  2019-10-20       Impact factor: 1.510

Review 2.  Laparoscopic colposuspension for urinary incontinence in women.

Authors:  Nicola Dean; Gaye Ellis; G Peter Herbison; Don Wilson; Atefeh Mashayekhi
Journal:  Cochrane Database Syst Rev       Date:  2017-07-27

Review 3.  Transvaginal mesh or grafts compared with native tissue repair for vaginal prolapse.

Authors:  Christopher Maher; Benjamin Feiner; Kaven Baessler; Corina Christmann-Schmid; Nir Haya; Jane Marjoribanks
Journal:  Cochrane Database Syst Rev       Date:  2016-02-09

Review 4.  Surgery for women with pelvic organ prolapse with or without stress urinary incontinence.

Authors:  Kaven Baessler; Corina Christmann-Schmid; Christopher Maher; Nir Haya; Tineke J Crawford; Julie Brown
Journal:  Cochrane Database Syst Rev       Date:  2018-08-19

Review 5.  Open retropubic colposuspension for urinary incontinence in women.

Authors:  Marie Carmela M Lapitan; June D Cody; Atefeh Mashayekhi
Journal:  Cochrane Database Syst Rev       Date:  2017-07-25
  5 in total
  2 in total

1.  Risk factors of postpartum stress urinary incontinence in primiparas: What should we care.

Authors:  Jiejun Gao; Xinru Liu; Yan Zuo; Xiaocui Li
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

2.  Long-term Urinary Outcomes After Transvaginal Uterovaginal Prolapse Repair With and Without Concomitant Midurethral Slings.

Authors:  Lauren Giugale; Amaanti Sridhar; Kimberly L Ferrante; Yuko M Komesu; Isuzu Meyer; Ariana L Smith; Deborah Myers; Anthony G Visco; Marie Fidela R Paraiso; Donna Mazloomdoost; Marie Gantz; Halina M Zyczynski
Journal:  Female Pelvic Med Reconstr Surg       Date:  2022-03-01       Impact factor: 2.091

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.